Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome

Last updated: February 25, 2026
Sponsor: University Hospital, Clermont-Ferrand
Overall Status: Active - Recruiting

Phase

N/A

Condition

Autism

Tic Disorders

Treatment

Rathus Assertiveness scale

Clinical Study ID

NCT06136572
RNI 2023 JALENQUES
  • Ages > 18
  • All Genders

Study Summary

The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Tourette syndrome

  • Participants aged 18 years or over

Exclusion

Exclusion Criteria:

  • Participants under legal protection

  • Inability to complete questionnaires alone

Study Design

Total Participants: 350
Treatment Group(s): 1
Primary Treatment: Rathus Assertiveness scale
Phase:
Study Start date:
May 06, 2024
Estimated Completion Date:
November 05, 2026

Connect with a study center

  • CHU Clermont-Ferrand

    Clermont-Ferrand 3024635, France
    France

    Active - Recruiting

  • CHU Clermont-Ferrand

    Clermont-Ferrand,
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.